These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38001714)

  • 1. The m
    Xie J; Mo T; Li R; Zhang H; Liang G; Ma T; Chen J; Xie H; Wen X; Hu T; Xian Z; Pan W
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
    Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
    J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction.
    Wen Z; Sun J; Luo J; Fu Y; Qiu Y; Li Y; Xu Y; Wu H; Zhang Q
    Front Oncol; 2022; 12():1049345. PubMed ID: 36530986
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Deng J; Zhang J; Ye Y; Liu K; Zeng L; Huang J; Pan L; Li M; Bai R; Zhuang L; Huang X; Wu G; Wei L; Zheng Y; Su J; Zhang S; Chen R; Lin D; Zheng J
    Cancer Res; 2021 Oct; 81(20):5268-5283. PubMed ID: 34362795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m7G-related genes-NCBP2 and EIF4E3 determine immune contexture in head and neck squamous cell carcinoma by regulating CCL4/CCL5 expression.
    Xu X; Zhao Y; Ying Y; Zhu H; Luo J; Mou T; Zhang Z
    Mol Carcinog; 2023 Aug; 62(8):1091-1106. PubMed ID: 37067401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIRBP Knockdown Attenuates Tumourigenesis and Improves the Chemosensitivity of Pancreatic Cancer via the Downregulation of DYRK1B.
    Chen X; Xie H; Wang X; Zheng Z; Jin S
    Front Cell Dev Biol; 2021; 9():667551. PubMed ID: 34490236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N
    Tian J; Zhu Y; Rao M; Cai Y; Lu Z; Zou D; Peng X; Ying P; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
    Gut; 2020 Dec; 69(12):2180-2192. PubMed ID: 32312789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis-related genes regulate proliferation and invasion of pancreatic cancer and serve as the prognostic signature for modeling patient survival.
    Song W; Liu Z; Wang K; Tan K; Zhao A; Li X; Yuan Y; Yang Z
    Discov Oncol; 2022 May; 13(1):39. PubMed ID: 35633405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (
    Bu H; Cao T; Li X; Guo Y; Guo J; Wang Y; Sun Y; Wang D
    J Gastrointest Oncol; 2022 Aug; 13(4):1782-1792. PubMed ID: 36092349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer.
    Zhou S; Zhong Z; Lu Y; Li Y; Yao H; Zhao Y; Guo T; Yang K; Li Y; Chen S; Huang K; Lian G
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer.
    Wang J; Guo T; Zhang X; Guo J; Meng X; Yan S; Wang Y; Xiao Y; Xu W; Wei X; Ding K; Zhang J; Mi Y; Wu S; Chen J; Huang Y; Ren S; Hou J
    Transl Oncol; 2024 Sep; 47():102049. PubMed ID: 38964031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro.
    Qian X; Bi QY; Wang ZN; Han F; Liu LM; Song LB; Li CY; Zhang AQ; Ji XM
    J Ethnopharmacol; 2023 May; 307():116198. PubMed ID: 36690307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
    Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
    Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications.
    Yang J; Ren B; Ren J; Yang G; Fang Y; Wang X; Zhou F; You L; Zhao Y
    J Exp Clin Cancer Res; 2023 Jun; 42(1):155. PubMed ID: 37370109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
    Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
    Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer.
    Yang K; Li Y; Lian G; Lin H; Shang C; Zeng L; Chen S; Li J; Huang C; Huang K; Chen Y
    Int J Cancer; 2018 Jun; 142(11):2323-2334. PubMed ID: 29315556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.